| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Editas Medicine, Inc. (EDIT) has 3 insiders with recent SEC Form 4 filings, including 0 buys and 20 sells. EDIT is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 269.1K | $672.7K | - | |
| VP | 68.8K | $171.9K | - | |
| CFO | 15.9K | $39.8K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Dec 18, 2018 | Myer Vickesh | Chief Technology Officer | Sale+OE | 7,000 | $27.61 | $193,303.00 | -90.9% | |
| Dec 3, 2018 | Bosley Katrine | President And CEO | Sell | 12,000 | $31.92 | $383,087.00 | -0.5% | |
| Nov 23, 2018 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 5,284 | $28.15 | $148,738.76 | -98.1% | |
| Nov 20, 2018 | Myer Vickesh | Chief Technology Officer | Sale+OE | 7,000 | $27.23 | $190,579.00 | -100% | |
| Nov 1, 2018 | Bosley Katrine | President And CEO | Sell | 12,000 | $26.88 | $322,508.00 | -0.5% | |
| Oct 26, 2018 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 6,000 | $25.70 | $154,200.00 | -100% | |
| Oct 18, 2018 | Myer Vickesh | Chief Technology Officer | Sale+OE | 7,000 | $29.20 | $204,370.00 | -100% | |
| Oct 1, 2018 | Bosley Katrine | President And CEO | Sell | 12,000 | $31.02 | $372,292.80 | -0.5% | |
| Sep 28, 2018 | Hack Andrew A. F.62 | Chief Financial Officer | Sale+OE | 8,000 | $32.08 | $256,640.00 | -100% | |
| Sep 18, 2018 | Myer Vickesh | Chief Technology Officer | Sale+OE | 7,000 | $32.25 | $225,750.00 | -100% |